感谢您的提交
有人会很快与你联系
有人会很快与你联系
为生命科学提供基于云的综合软件解决方案的领先供应商ArisGlobal宣布，中国FDA药物评估中心选择并通过其当地合作伙伴实施了临床安全
ArisGlobal的LifeSphere®安全平台提供跨所有组织业务部门的人工智能和认知计算方面的最新进展2017年11月14日，佛罗里达州迈阿密 – ArisGl
LifeSphere MultiVigilance是任何全球药物警戒软件公司可全面满足中国制造商的药物警戒要求的第一款软件 应用程序
Mark是一位经验丰富的金融领导者，最近担任纽约证券交易所上市公司Teladoc Health的首席运营官兼首席财务官。 Mark拥有大约30年的执行财务管理经验，拥有众多创业企业。 Mark此前曾担任RCS和Media Monitors（一家国际软件技术公司）的首席财务官，以及BT Radianz的首席财务官，BT Radianz是全球最大的全球金融外联网，负责指导公司的20家国内和国外子公司。 他的经验还包括在Deltathree的RSL Communications担任领导职务。 Mark于1987年在纽约的Deloitte开始了自己的职业生涯。
在加入ArisGlobal之前，David曾担任Synowledge的董事长达7年多，并在Synowledge 于2015年被Bioclinica收购之前的发展中发挥了不可或缺的作用。他在交付，客户关系和运营方面担任过各种关键职位，以确保所有项目都成功交付，并满足法规、质量和客户要求。 随着公司从不到10名员工发展到全球1,000多名员工，David管理着美国，南美，欧盟和印度的团队，并创建了各部门的流程。 在Bioclinica收购Synowledge之后，David成为美国的客户服务总监，负责管理位于美国的药品安全和监管解决方案团队的所有美国BPO和IT项目。
Sam负责ArisGlobal营销战略和执行的各个方面，为企业软件领域的市场战略定义提供丰富的经验支持。 在加入ArisGlobal之前，Sam曾领导Exela Technologies的生命科学和保险业务部门，该公司是HGM和Apollo Global Management的上市投资组合公司，专注于数字化转型和自动化。 在Exela，Sam负责制定和执行市场战略，监理销售和客户合作伙伴以及营销战略。 在加入Exela之前，Sam曾在Google，Crowdtap和Gray Advertising等多家科技公司从事营销和业务开发，并在Synowledge的早期团队任职。Sam拥有加州大学洛杉矶分校安德森管理学院的MBA学位和范德比尔特大学的学士学位。
Sharad Prakash负责ArisGlobal的LifeSphere安全分析和风险管理业务部门，负责管理公司的信号检测和风险管理产品。 此前，Sharad是Medsight Solutions的创始人/首席执行官（后来被ArisGlobal收购），在那里他创建了Medsight Sapphire，一个用于药物警戒风险管理的信号和决策分析平台。 Sharad拥有超过16年的经验，与众多制药组织和监管机构密切合作，共同担任关键领导角色，为生命科学解决方案制定战略方向。 Sharad拥有Kharagpur印度理工学院的学士学位和纽约大学斯特恩商学院的MBA学位。
Georgia Papathomas is the SVP and Global Head of Data Sciences for Johnson & Johnson. In this position, Georgia’s goals are to evolve and establish the J&J Data Sciences Strategy, including the development of the strategy, the planning, and the implementation of plans for the use of sophisticated analytics and Artificial Intelligence capabilities across J&J. Data Sciences and Big Data is positioned as a key enabler in J&J’s efforts to continuously innovate and transform to a Science and Technology company.
Prior to this position, Georgia was VP and Group Chief Information Officer for Janssen, the J&J Pharmaceutical Companies, and a member of the J&J Pharmaceuticals Group Operating Committee (GOC). In this position, Georgia’s goals included: defining a business/technology strategy accounting for the changing landscape of delivering optimal care and enhanced patient outcomes, while disrupting business models and transforming business operations; developing and delivering Digital health solutions impacting patient care and improving the continuum of care that includes, payors and providers; driving innovation in IT and creating competitive advantage for the business through the use of AI and Big Data; influencing changes in Health IT; and building a strong and engaged global IT team.
Prior to joining J&J, Georgia held the position of Senior Vice President-Chief Information Officer and Corporate Innovation Officer at Boehringer Ingelheim Pharmaceutical in Ridgefield, Connecticut. She was a member of the BI-Pharmaceuticals Executive Leadership Team.
Georgia has worked with Pfizer as the Chief Technology Officer (CTO) for EMEA and as Vice President-Global Customer Service Management; Lucent Technologies as Vice President-Global Professional Services/Network Solutions; and started her career as a researcher at AT&T Bell Labs.
Georgia received her Ph.D. in Engineering Science; her M.S. in Engineering Mechanics as a Sloan Fellow; and her B.S. in Civil Engineering all from Columbia University in New York.
Among her many affiliations, she is on the Executive Board of the National Center for Women & Information Technology; on the the Board of Advisors of the Columbia University School of Engineering and Applied Sciences; on the Executive Committee on Data & Society, chaired by the president of Columbia University; on the NJ CIO Executive Board; and on the Board of advisors for Salesforce Inc.
Georgia is also a member of the New York Academy of Sciences, the Sigma Xi Research Honor Society, the American Association for the Advancement of Science AAAS, The Pharmaceutical Information Systems Association PISA, the CIO Research Board, and the Executive Women’s technology Forum SWIFT.
Pratyusha has over 13 years of experience in software product management for Life Sciences & Healthcare Industry. She has been with ArisGlobal for 9 years, working in Regulatory, Enterprise Business Analytics and Clinical teams. In her current role as Associate Director – Regulatory Product Management, she is responsible for steering long term product roadmap and conceiving business proposals for turnkey concepts of ArisGlobal’s regulatory solutions. She leads the Regulatory Industry Standard Practice initiative that delivers products with pre-built best practices built in conjunction with customers. She also engages in bid defence engagements and solution evaluations for turnkey prospects in US region. Pratyusha is based in Princeton New Jersey US. Prior to joining ArisGlobal, Pratyusha was with GE Healthcare leading teams to define and build Electronic Health Records and Clinical Information Systems. Pratyusha holds a Bachelor degree in Engineering (Computer Science) and Masters in Business Administration degree with specialization in Information Management.
Katsuhiko是ArisGlobal日本办事处的区域总监，负责对接日本、中国和韩国的客户。在加入ArisGlobal之前，Katsuhiko是一家医疗市场研究公司WorldOne K.K.的日本总裁。 Katsuhiko还为Phase Forward Japan K.K.工作。 2000年担任销售总监，并于2006年晋升为日本总裁.Katsuhiko的职业生涯开始于勃林格殷格翰日本公司的MR，GlaxoSmithKline K.K.的市场营销，并且是Luminary Medical K.K.的创始人。 Katsuhiko毕业于同志社大学法学院。 在京都。
Sai负责监督ArisGlobal的所有工程和全球安全客户支持实践。 在此职位上，他与内部产品管理和流程组织团队密切合作，设计创新，高度可扩展且高性能的云就绪应用程序。 在加入ArisGlobal之前，Sai曾在Aptean（前身为Consona Inc.）担任工程副总裁。 在他任职期间，Sai还管理了Aptean的所有印度业务，持有领导力。Sai在软件工程领域工作超过15年，在1985年获得印度Annamalai大学毕业文凭的许多证书之前完成了工程学。
Aman是ArisGlobal的全球药物警戒和全球客户合作伙伴组织的负责人。作为全球药物警戒负责人，Aman负责ArisGlobal安全业务部门的产品战略规划和执行。他还负责监督ArisGlobal的认知自动化战略。在他的职业生涯中，Aman为各种全球组织管理了端到端的药物警戒运营和业务战略。在加入ArisGlobal之前，他管理了一个大型全球药物警戒运营小组，负责案例管理（每年约100万ICSR），汇总报告和信号服务。他还曾在诺华公司工作过，从而将药品和服务视角融入到产品战略中。
Aman还管理全球客户合作伙伴组织，负责ArisGlobal全球现有客户的商业和客户管理战略。他的职责将Aman独特地定位于产品管理，路线图规划和发布管理领域的客户/商业见解。
Wim Cypers已经在ArisGlobal工作将近25年了。在这个职位上，他领导所有监管业务部门的运营，包括整体产品愿景，战略，实施以及ArisGlobal监管解决方案套件的成功。Wim在将业务需求转换为应用程序功能方面拥有长期经验; 并在IDMP等领域始终如一地展示行业思想领导力。 他将药剂师培训应用于对如何解决复杂业务问题的敏锐理解。 在专注于ArisGlobal的监管业务部门之前，Wim负责管理公司的安全和监管解决方案的战略和产品管理职能。 在加入ArisGlobal之前，Wim曾在比利时的Janssen研究基金会工作。 他毕业于Katholieke Universiteit Leuven，担任工业药剂师。同样带着对太空飞行器的热情他现在在比利时工作，和家人住在一起。
Manish VarmaChief Strategy Officer, ArisGlobal
Manish is responsible for all aspects of marketing, management, business strategy, and technology. Prior to joining ArisGlobal, Manish was the Global Vice President of Products, Portfolio, and Information Technology for Janssen Pharmaceutical companies of Johnson & Johnson. Before joining J&J, Manish founded and managed a boutique consulting firm that helped major corporations apply emerging technologies to disrupt established business models.
In addition to his experience in healthcare, Manish worked in Citibank and developed application ecosystem for high-frequency trading. Manish holds a Bachelor of Technology degree from Indian Institute of Technology (IIT) and MBA from The Wharton School, University of Pennsylvania. Manish will be based in our Princeton office.
